Henry Schein, Inc. (NASDAQ:HSIC) is one of the 11 Best Mid-cap Healthcare Stocks to Buy According to Hedge Funds.

Today we are looking at Henry Schein (NASDAQ:HSIC) and the best and worst performers in the dental equipment & technology industry.

Henry Schein has outperformed the Dow over the past year, and analysts remain moderately optimistic about the stock’s prospects.

Henry Schein, Inc.’s HSIC joint venture, Henry Schein One, is driving strong growth in its core products and introducing new solutions. The company’s robust acquisition strategy helps it to pursue ...

Henry Schein, Inc. (NASDAQ:HSIC) is one of the 13 Cheap Mid-Cap Stocks to Add to Your Portfolio. On June 16, Leerink Partners analyst Michael Cherny maintained a Hold rating on Henry Schein, Inc.

Henry Schein Inc. closed 9.71% below its 52-week high of $82.49, which the company reached on February 5th.

Taking full advantage of the stock market and investing with confidence are common goals for new and old investors, and Zacks Premium offers many different ways to do both. Featuring daily updates of ...

Biotech is a provider of dental implants, clear aligners, and innovative digital dental software based in Salon-de-Provence, France.

Henry Schein Dental UK | 7,785 followers on LinkedIn. Rely on Us | Follow Us To Hear About… - The latest news and statistics in the dental industry at your fingertips - Our latest company news ...